Ronald L. Stotish, Ph.D. was named CEO and President of Aqua Bounty Technologies in May 2008. Ron joined Aqua Bounty Technologies in 2006 as Vice President for Regulatory Affairs, and most recently was Senior Vice President for R&D and Regulatory Affairs. Prior to joining Aqua Bounty, Ron was Executive Vice President for R&D at MetaMorphix, Inc. He has served as Vice President for Global Pharmaceutical Research and Development at Fort Dodge Animal Health, and held a variety of positions at American Cyanamid. He began his career in basic research at Merck. Ron has degrees in Biochemistry, andover forty years experience in the discovery, development, and commercialization of new animal health products. Ron is a member of the Board of Directors of BIO, the Biotechnology Industry Organization, and also serves on the Food and Agriculture Section Governing Board of BIO. He is a member of the World Aquaculture Society, Global Aquaculture Alliance, and the American Association for the Advancement of Science.